Mitsubishi UFJ Asset Management’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.11K | Hold |
172
| – | – | ﹤0.01% | 1503 |
|
2025
Q1 | $4.27K | Hold |
172
| – | – | ﹤0.01% | 1477 |
|
2024
Q4 | $3.17K | Hold |
172
| – | – | ﹤0.01% | 1536 |
|
2024
Q3 | $2.59K | Hold |
172
| – | – | ﹤0.01% | 1558 |
|
2024
Q2 | $4.92K | Sell |
172
-6,177
| -97% | -$177K | ﹤0.01% | 1377 |
|
2024
Q1 | $186K | Sell |
6,349
-283
| -4% | -$8.27K | ﹤0.01% | 967 |
|
2023
Q4 | $213K | Buy |
6,632
+1,529
| +30% | +$49K | ﹤0.01% | 1004 |
|
2023
Q3 | $157K | Buy |
5,103
+438
| +9% | +$13.4K | ﹤0.01% | 1045 |
|
2023
Q2 | $187K | Buy |
4,665
+513
| +12% | +$20.6K | ﹤0.01% | 1048 |
|
2023
Q1 | $169K | Buy |
4,152
+401
| +11% | +$16.4K | ﹤0.01% | 1041 |
|
2022
Q4 | $146K | Buy |
3,751
+821
| +28% | +$31.9K | ﹤0.01% | 1057 |
|
2022
Q3 | $156K | Buy |
2,930
+203
| +7% | +$10.8K | ﹤0.01% | 1054 |
|
2022
Q2 | $159K | Sell |
2,727
-1,380
| -34% | -$80.5K | ﹤0.01% | 1066 |
|
2022
Q1 | $313K | Buy |
4,107
+255
| +7% | +$19.4K | ﹤0.01% | 994 |
|
2021
Q4 | $236K | Buy |
+3,852
| New | +$236K | ﹤0.01% | 1057 |
|